Novozymes A/S (OTCMKTS:NVZMY – Get Free Report)’s share price passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $62.28 and traded as low as $55.74. Novozymes A/S shares last traded at $56.00, with a volume of 16,126 shares traded.
Analysts Set New Price Targets
A number of research firms have recently commented on NVZMY. Barclays upgraded shares of Novozymes A/S to a “strong-buy” rating in a research report on Monday, November 18th. Citigroup lowered shares of Novozymes A/S from a “neutral” rating to a “sell” rating in a research report on Thursday, October 17th.
Read Our Latest Report on NVZMY
Novozymes A/S Trading Down 2.1 %
About Novozymes A/S
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
Read More
- Five stocks we like better than Novozymes A/S
- ESG Stocks, What Investors Should Know
- How to Invest in Small Cap Stocks
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- These Are the Dividend Stocks Insiders Bought in January
- What to Know About Investing in Penny Stocks
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.